Recruiting
Phase 2

Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease

Sponsor:

Stemedica Cell Technologies, Inc.

Code:

NCT02833792

Conditions

Alzheimer Dementia

Eligibility Criteria

Sex: All

Age: 55 - 70+

Healthy Volunteers: Not accepted

Interventions

Human Mesenchymal Stem Cells and Lactated Riunger's Solution

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information